STING/type I interferon pathway is required for antigen-containing PLGA nanoparticle- and apoptotic cell–induced CD4+ T cell tolerance
Open Access
- 2 January 2026
- journal article
- immunology
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (1) , eadv8860
Abstract
Autoreactive CD4 + T cell infiltration, tissue destruction, and spread epitope–specific CD4 + T cell activation underly CD4 + T cell–mediated autoimmune disease pathogenesis. Here, we identify previously unknown pathways required for antigen (Ag)–specific tolerogenic immune-modifying particle/Cour nanoparticle (TIMP/CNP)–induced tolerance. The data show that myeloid cells phagocytose CNPs, undergo apoptosis, and release oxidized DNA [8-hydroxy-2′-deoxyguanosine (8-OHG)]. Subsequently, Ag-specific CNP treatment increases the number of PD-L1 + cDC2 dendritic cells and the number of FoxP3 + , CTLA-4 + , PD-1 + , and IL-10 + regulatory CD4 + T cells via a stimulator of interferon genes (STING)/interferon-α/β receptor (IFNAR)–dependent pathway. In addition, these same pathways were found to be required for both Ag-coupled apoptotic leukocyte–induced and Ag-coupled red blood cell treatment–induced CD4 + T cell tolerance. Together, these results show that Ag-specific tolerance induced by the presence of apoptotic cells, and by CNP-induced apoptosis, requires the STING/IFNAR pathway, thereby illustrating a previously unknown function of this pathway.Keywords
Funding Information
- National Institutes of Health (R01AI148076)
- Juvenile Diabetes Research Foundation (3-PDF-2018-582-A-N)
- Cour Pharmaceuticals
- Johnnie Walkers MS Foundation
- Amy and David Fulton Foundation
- Crammer Family Foundation
- Thomas and Deige McLaughlin Foundation
- Rottering Family Foundation
This publication has 59 references indexed in Scilit:
- Peripheral Tolerance Induction Using Ethylenecarbodiimide-Fixed APCs Uses both Direct and Indirect Mechanisms of Antigen Presentation for Prevention of Experimental Autoimmune EncephalomyelitisThe Journal of Immunology, 2007
- CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAENature Immunology, 2007
- Cutting Edge: Anti-CD25 Monoclonal Antibody Injection Results in the Functional Inactivation, Not Depletion, of CD4+CD25+ T Regulatory CellsThe Journal of Immunology, 2006
- Pathologic Role and Temporal Appearance of Newly Emerging Autoepitopes in Relapsing Experimental Autoimmune EncephalomyelitisThe Journal of Immunology, 2000
- The Nature of the Principal Type 1 Interferon-Producing Cells in Human BloodScience, 1999
- Epitope spreadingCurrent Opinion in Immunology, 1996
- Antagonism of interferon beta on interferon gamma: inhibition of signal transduction in vitro and reduction of serum levels in multiple sclerosis patientsMultiple Sclerosis Journal, 1995
- MARGINAL METALLOPHILIC CELLS OF THE MOUSE SPLEEN IDENTIFIED BY A MONOCLONAL-ANTIBODY1986
- MARGINAL ZONE MACROPHAGES IDENTIFIED BY A MONOCLONAL-ANTIBODY - CHARACTERIZATION OF IMMUNO-HISTOCHEMICAL AND ENZYME-HISTOCHEMICAL PROPERTIES AND FUNCTIONAL CAPACITIES1985
- The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.Journal of Experimental Medicine, 1979